KR20150111919A - 글라티라머 아세테이트의 경구 경점막 전달 - Google Patents

글라티라머 아세테이트의 경구 경점막 전달 Download PDF

Info

Publication number
KR20150111919A
KR20150111919A KR1020157019730A KR20157019730A KR20150111919A KR 20150111919 A KR20150111919 A KR 20150111919A KR 1020157019730 A KR1020157019730 A KR 1020157019730A KR 20157019730 A KR20157019730 A KR 20157019730A KR 20150111919 A KR20150111919 A KR 20150111919A
Authority
KR
South Korea
Prior art keywords
film composition
present
amount
weight
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020157019730A
Other languages
English (en)
Korean (ko)
Inventor
우르술라 가이스터
스테판 슈바이처
마르티나 뷔르거
랄프 슈테판
제랄드 후버
타냐 프라이스
Original Assignee
테바 파마슈티컬 인더스트리즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테바 파마슈티컬 인더스트리즈 리미티드 filed Critical 테바 파마슈티컬 인더스트리즈 리미티드
Publication of KR20150111919A publication Critical patent/KR20150111919A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157019730A 2012-12-21 2013-12-20 글라티라머 아세테이트의 경구 경점막 전달 Withdrawn KR20150111919A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261745243P 2012-12-21 2012-12-21
US61/745,243 2012-12-21
PCT/US2013/077041 WO2014100643A1 (en) 2012-12-21 2013-12-20 Oral transmucosal delivery of glatiramer acetate

Publications (1)

Publication Number Publication Date
KR20150111919A true KR20150111919A (ko) 2015-10-06

Family

ID=50979258

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157019730A Withdrawn KR20150111919A (ko) 2012-12-21 2013-12-20 글라티라머 아세테이트의 경구 경점막 전달

Country Status (15)

Country Link
US (1) US20150328277A1 (cg-RX-API-DMAC7.html)
EP (1) EP2934493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016503066A (cg-RX-API-DMAC7.html)
KR (1) KR20150111919A (cg-RX-API-DMAC7.html)
CN (1) CN104869984A (cg-RX-API-DMAC7.html)
AU (1) AU2013361057A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015014092A2 (cg-RX-API-DMAC7.html)
CA (1) CA2895457A1 (cg-RX-API-DMAC7.html)
EA (1) EA201591187A1 (cg-RX-API-DMAC7.html)
HK (2) HK1214522A1 (cg-RX-API-DMAC7.html)
IL (1) IL239279A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015007794A (cg-RX-API-DMAC7.html)
SG (1) SG11201504461QA (cg-RX-API-DMAC7.html)
WO (1) WO2014100643A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201505050B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025780B1 (ru) 2010-10-11 2017-01-30 Тева Фармасьютикал Индастриз Лтд. Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
MX2014004309A (es) 2011-10-10 2015-07-06 Teva Pharma Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
US10323289B2 (en) 2017-06-26 2019-06-18 Institut Pasteur Treatments to eliminate HIV reservoirs and reduce viral load

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US7022663B2 (en) * 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
US20070021325A1 (en) * 2005-07-21 2007-01-25 Mediplex Corporation Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2008006226A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
AU2007329375A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
JP5177447B2 (ja) * 2007-06-07 2013-04-03 佐藤製薬株式会社 速溶性及び可撓性を有するフィルム製剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US20100278899A1 (en) * 2007-12-06 2010-11-04 Lintec Corporation Edible film

Also Published As

Publication number Publication date
WO2014100643A1 (en) 2014-06-26
JP2016503066A (ja) 2016-02-01
ZA201505050B (en) 2016-10-26
CN104869984A (zh) 2015-08-26
SG11201504461QA (en) 2015-07-30
HK1214522A1 (zh) 2016-07-29
WO2014100643A8 (en) 2015-06-25
EP2934493A4 (en) 2016-09-07
HK1214133A1 (zh) 2016-07-22
EP2934493A1 (en) 2015-10-28
EA201591187A1 (ru) 2016-03-31
CA2895457A1 (en) 2014-06-26
US20150328277A1 (en) 2015-11-19
AU2013361057A1 (en) 2015-07-30
BR112015014092A2 (pt) 2017-07-11
MX2015007794A (es) 2015-09-04
IL239279A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
US20240123010A1 (en) Pharmaceutical composition and method of manufacturing
JP6063385B2 (ja) Ｈｉｖ関連の下痢を治療するための方法および組成物
RU2611403C1 (ru) Составы в форме спрея для перорального введения и способы введения силденафила
US12390470B2 (en) 1-methylxanthine-based bioactive composition and method of use thereof
KR20090043528A (ko) 알리스키렌의 갈레닉 제제
US10874607B2 (en) Isotretinoin oral-mucosal formulations and methods for using same
US20150328277A1 (en) Oral transmucosal delivery of glatiramer acetate
GB2587934A (en) Intranasal epinephrine formulations and methods for the treatment of disease
BG63862B1 (bg) Фармацевтични състави, съдържащи инхибитори на моноаминоксидаза в
KR20150111918A (ko) 글라티라머 아세테이트의 경점막 전달
TW202228682A (zh) 使用右美托咪啶(dexmedetomidine)鹽酸鹽治療躁鬱症及精神病
JP2011502132A (ja) 改善された錠剤コーティング
KR20150016382A (ko) 두통을 예방하기 위한 조성물
WO2015195605A1 (en) Transmucosal delivery of glatiramer acetate by oral patches
KR20150126382A (ko) 위 내의 알데하이드에 결합하는 캡슐화된 조성물
CN104125834A (zh) 含有北美鹅掌楸树皮提取物作为活性成分的药物组合物
WO2016151461A1 (en) Sublingual film of ketorolac
AU2018392074C1 (en) Sheet formulation for oral use
JP2026003867A (ja) 嚥下機能改善剤
ES2394906B1 (es) Uso de la l-carnitina y sus composiciones para el tratamiento y la prevención de la fibrosis renal.
JP2014047154A (ja) ペルオキシナイトライト生成抑制剤
HK40078493A (en) Apoaequorin and curcumin containing compositions and methods
WO2003026634A1 (es) Aminas como agentes anti-alcoholismo
JPWO2005013970A1 (ja) 肝胆道系障害改善剤
KR20130025990A (ko) Ｃ３ｇ 또는 이를 함유하는 오디 추출물을 포함하는 당뇨병성 발기부전의 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000